Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

Business / Technology


Our network sites seattletimes.com | Advanced

Originally published January 8, 2007 at 12:00 AM | Page modified January 8, 2007 at 2:01 PM

E-mail E-mail article      Print Print      Share Share

Seattle Genetics shares jump on Genentech agreement

Seattle Genetics shares rose as much as 31 percent after the company agreed with Genentech Inc. to develop blood-cancer treatments.

Bloomberg

Seattle Genetics shares rose as much as 31 percent after the company agreed with Genentech Inc. to develop blood-cancer treatments.

Genentech will pay Seattle Genetics $60 million to co- develop an experimental treatment for multiple myeloma and other blood cancers, the companies said today.

Seattle Genetics, based in Bothell, may receive as much as $800 million from South San Francisco-based Genentech if the therapy, a so-called monoclonal antibody, passes certain development and sales guidelines for multiple diseases, the companies said in a statement.

Genentech's worldwide licensing agreement covers development and commercialization of SGN-40, Seattle Genetics' most advanced drug candidate. SGN-40 is currently in Phase I and Phase II clinical trials for multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Seattle Genetics shares increased by $1.35, or 26 percent, to $6.64 in mid-morning Nasdaq trading.

Seattle Times staff contributed to this report.

E-mail E-mail article      Print Print      Share Share

More Business & Technology

UPDATE - 09:46 AM
Exxon Mobil wins ruling in Alaska oil spill case

UPDATE - 09:32 AM
Bank stocks push indexes higher; oil prices dip

UPDATE - 08:04 AM
Ford CEO Mulally gets $56.5M in stock award

UPDATE - 07:54 AM
Underwater mortgages rise as home prices fall

NEW - 09:43 AM
Warner Bros. to offer movie rentals on Facebook

More Business & Technology headlines...

advertising


Get home delivery today!

Video

Advertising

AP Video

Entertainment | Top Video | World | Offbeat Video | Sci-Tech

Marketplace

 
Most read
Most commented
Most e-mailed
 
 

Most viewed imagesMore

Advertising